I have read an article on this new treatment, and last sentence of
the article states that "as a next step, researchers will look to better
understand the mechanism of action to further improve ongoing
clinical trials in humans." Luckily YF does understand the
"mechanism of action" and seems further improvement for this
treatment is being sought. So I believe they will not have this
available for a few years yet. Also stated not certain whether this
treatment would continue in tablet form so not a threat to Imugene
I think.
I have read an article on this new treatment, and last sentence...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.005(7.14%) |
Mkt cap ! $548.9M | |||
| Open | High | Low | Value | Volume |
| 7.1¢ | 7.6¢ | 7.1¢ | $1.896M | 25.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 3194318 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 331280 | 7 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.6¢ |
Change
0.005 ( 6.34 %) |
||||
| Open | High | Low | Volume | ||
| 7.1¢ | 7.6¢ | 7.1¢ | 15199158 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| IMU (ASX) Chart |